The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Glofitamab monotherapy in patients with heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL): Updated analysis from a phase I/II study.
 
Tycel Jovelle Phillips
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca; Bayer; BeiGene; BMS GmbH & Co. KG; Epizyme; Genentech; Genmab; Gilead Sciences; Incyte; Janssen; Kite/Gilead; Lilly; Merck; Pharmacyclics
Research Funding - Abbvie; Genentech
 
Carmelo Carlo-Stella
Honoraria - ADC Therapeutics; AstraZeneca; Celgene/Bristol-Myers Squibb; Gilead Sciences; Incyte; Janssen Oncology; Merck Sharp & Dohme; Novartis; Roche; SOBI; Takeda
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Celgene/Bristol-Myers Squibb; Janssen Oncology; Karyopharm Therapeutics; Novartis; Roche; Sanofi; Scenic Biotech; SOBI
Research Funding - ADC Therapeutics (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Roche; Takeda
Other Relationship - Roche
 
Franck Morschhauser
Honoraria - Chugai/Roche; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Genmab; Gilead Sciences; Modex therapeutics; Novartis; Roche/Genentech
 
Emmanuel Bachy
Honoraria - Amgen; Gilead Sciences; Incyte; Janssen-Cilag; Novartis; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Incyte; Novartis; Novartis; Roche; Takeda
Research Funding - Amgen Foundation (Inst); Bristol Myers Squibb Foundation (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Incyte; Janssen-Cilag; Roche
 
Michael Crump
Honoraria - Kyte-Gilead; Novartis
Research Funding - Roche
 
Marek Trneny
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche; SOBI; Swixx BioPharma; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Autolus; Bristol-Myers Squibb; Caribou Biosciences; Genmab; Gilead Sciences; Incyte; Janssen; MorphoSys; Novartis; Roche; SOBI; Takeda
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Gilead Sciences; janssen; Roche; SOBI; Takeda
 
Nancy L. Bartlett
Consulting or Advisory Role - Foresight Diagnostics; Genmab/AbbVie (Inst); Kite, a Gilead company; Roche/Genentech
Research Funding - ADC Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb/Celgene; Forty Seven (Inst); Janssen (Inst); Kite, a Gilead company; Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Jan Zaucha
Honoraria - Abbvie; Roche; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Novartis; Pfizer; Pierre Fabre; Roche; Takeda
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Abbvie; Roche
 
Tomasz Wrobel
Honoraria - Amgen; BeiGene; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche; Takeda
Consulting or Advisory Role - Amgen; BeiGene; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Roche; Takeda
Speakers' Bureau - Amgen; BeiGene; Gilead Sciences; Janssen; Novartis; Roche; Takeda
Research Funding - Amgen; Roche
 
Fritz Offner
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Novartis; Roche
 
Audrey Filézac de L’Etang
Employment - Roche
Stock and Other Ownership Interests - Roche (Inst)
Travel, Accommodations, Expenses - Roche (Inst)
 
James Relf
Employment - Roche
Stock and Other Ownership Interests - F-Star Biotechnology; Roche
 
David J. Carlile
Employment - Roche
Stock and Other Ownership Interests - AstraZeneca; Roche
Patents, Royalties, Other Intellectual Property - Roche
 
Ben Byrne
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Estefania Mulvihill
Employment - Roche; Roche (I)
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Roche
 
Linda Lundberg
Employment - Roche; Roche (I)
Stock and Other Ownership Interests - Roche; Roche (I)
Patents, Royalties, Other Intellectual Property - Roche; Roche (I)
 
Michael Dickinson
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; Novartis; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Genmab; Gilead Sciences; Janssen; Novartis; Roche (I)
Research Funding - Abbvie (Inst); Celgene (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche